Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Case of Oriental Obesity Treatment's Effect on Improvement of Nonalcoholic Steatohepatitis Patient's Liver Function

한방비만치료를 통한 비알코올성 지방간염 의증 환자의 간기능 개선 1례 보고

  • Choi, Bin-Hye (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University) ;
  • Kim, Dong-Woo (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University) ;
  • Park, Kyung (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University) ;
  • Kim, Dae-Jun (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University) ;
  • Byun, Joon-Seok (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University) ;
  • Hur, Jin-Il (3rd Department of Internal Medicine, College of Oriental Medicine, Daegu Hanny University)
  • 최빈혜 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 김동우 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 박경 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 김대준 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 변준석 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 허진일 (대구한의대학교 한의과대학 비계내과학교실)
  • Published : 2006.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Nonalcoholic steatohepatitis(NASH) may progress to advanced liver disease. The diagnosis is made on liver biopsy when investigating a patient with raised transaminases and an otherwise negative biochemical and serological work-up. The subject was a obese male patient who had unexplained raised GOT, GPT. He had no alcoholic consumption and drug ingested. On serological examination, HBsAg and Anti-HCV test are negative. The subject was diagnosed as NASH, and was treated with oriental treatment for obesity. After 2months treatment the raised GOT, GPT decreased to normal range.

Keywords

References

  1. 연종은. 비알코올성 지방간 질환의 임상적 의의. 가정의학회지 24:510-515, 2003
  2. 전국한의과대학 간계내과학교수 공저. 간계내과학. 서울, 동양의학연구원, pp 315-322. 2001
  3. 이정찬. 신사상의학론 II . 서울, 木과土. pp 358-360. 2003
  4. 조중현. 비알코올성 지방간질환의 치료. 대한간학회 singleTopic symposium. pp 78-82, 2003
  5. 권영오. 비만과 간질환. 제 7 회 대한소화기내시경학회 대구-경북지회 및 대구-경북소화기 학회 연수강좌. pp 8-11
  6. Diehl, A.M. Nonalcholic steatohepatitis. Semin Liver Dis. Cell 19:221-229, 1999 https://doi.org/10.1055/s-2007-1007111
  7. Bacon, B., Faravash, M.J., Janney, C.G. et al. Nonalcholic steatohepatitis: Anexpanded clinical entity. Gastroenterology. Cell 107:1103-1106, 1994 https://doi.org/10.1016/0016-5085(94)90235-6
  8. Sanyal, A.J. Nonalcholic steatohepatitis. Clin perapect Gastroenterology. Cell 3:1056-1060, 2000
  9. Angulo, P., Keach, J.C., Batts, K.P., Lindor, K.D. INdependent predictors of liver fibrosis in patients with nonalcholic steatohepatitis. Hepatology. Cell 30:1356-1362, 1999 https://doi.org/10.1002/hep.510300604
  10. George, D.K., Goldwurm, S., MacDonald, G.A. et al. Increased hepatic iron concentration in nonalcholic steatohepatitis is associated with increased fibrosis. Gastroenterology. Cell 114:311-318, 1998 https://doi.org/10.1016/S0016-5085(98)70482-2
  11. Ludwig, J., Viggiano, T.R., McGill, D.B., Oh, B.J. Nonalcholic steatohepatitis:Mayo clinic exoeriences with a hitherto unnamed disease. Mayo Clin Proc. Cell 55:434-438, 1980
  12. Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., McCullough, A.J. Nonalcholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. Cell 116:1413-1419, 1999 https://doi.org/10.1016/S0016-5085(99)70506-8
  13. Laurin, lindor, K.D., Crippin, J.S et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcholic induced steatohepatitis: a pilot study. Hepatology. Cell 23:74-80, 1996